Antineoplastic Agents, Hormonal
Concept
Vocabulary Service
Overview
subject area of
-
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer Academic Article
-
neu/erbB-2 Overexpression and Response to Hormonal Therapy in Premenopausal Women in the Adjuvant Breast Cancer Setting: Will It Play in Peoria? Part II Academic Article
-
A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen Academic Article
-
A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer Academic Article
-
A Phase II Study of Leuprolide in Advanced/Recurrent Endometrial Cancer Academic Article
-
A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer Academic Article
-
A Trial of Two Questions Academic Article
-
A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis Academic Article
-
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer Academic Article
-
A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1 Academic Article
-
A review of exemestane in the management of breast cancer Academic Article
-
A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer Academic Article
-
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy Academic Article
-
Activity of fulvestrant in HER2-overexpressing advanced breast cancer Academic Article
-
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer Academic Article
-
Adjuvant Endocrine Therapy for Postmenopausal Women with Early Breast Cancer Conference Paper
-
Adjuvant Endocrine Therapy in Hormone Receptor-Positive Postmenopausal Breast Cancer: Evolution of NCCN, ASCO, and St Gallen Recommendations Academic Article
-
Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis Academic Article
-
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial Academic Article
-
Adjuvant endocrine therapy for breast cancer: a commentary. Academic Article
-
Adjuvant endocrine therapy for breast cancer: longer therapy and the need for personalized treatment--should we treat beyond the data? Academic Article
-
Adjuvant hormonal therapy for premenopausal breast cancer: incorporating clinical experience. Academic Article
-
American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction Academic Article
-
American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002 Academic Article
-
An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer Academic Article
-
An update on adjuvant systemic therapy for elderly patients with early breast cancer Academic Article
-
Anastrozole as an Adjuvant Endocrine Treatment for Postmenopausal Patients with Breast Cancer: Emerging Data Conference Paper
-
Antihormone Therapy in Recurrent Metastatic Breast Cancer Academic Article
-
Aromatase Inhibitors in Adjuvant Therapy of Breast Cancer: Before, Instead of, or Beyond Tamoxifen Academic Article
-
Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review Academic Article
-
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Academic Article
-
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials Academic Article
-
Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women Academic Article
-
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial Academic Article
-
Attenuation of the Glucocorticoid Response during Ad5IL-12 Adenovirus Vector Treatment Enhances Natural Killer Cell–Mediated Killing of MHC Class I–Negative LNCaP Prostate Tumors Academic Article
-
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer Academic Article
-
Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer Academic Article
-
CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women: Lessons Learned Academic Article
-
Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer Academic Article
-
Chemoprevention: Drug pricing and mortality Academic Article
-
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer Academic Article
-
Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer Academic Article
-
Coagulopathy in a patient with nephrotic syndrome Academic Article
-
Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis Academic Article
-
Combining endocrine agents with chemotherapy: Which patients and what sequence? Conference Paper
-
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor–Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial Academic Article
-
Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene Academic Article
-
Controversies in prostate cancer radiotherapy: consensus development. Academic Article
-
Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer Academic Article
-
Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer? Academic Article
-
Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910 Academic Article
-
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers Academic Article
-
Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17 Academic Article
-
Effect of Single-agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-resistant Prostate Cancer: Pooled Analysis of Prospective Studies Academic Article
-
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer Academic Article
-
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93 Academic Article
-
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial Academic Article
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Academic Article
-
Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17 Academic Article
-
Endocrine and targeted manipulation of breast cancer: Summary statement for the Sixth Cambridge Conference Academic Article
-
Endocrine symptoms to predict risk of recurrence? Academic Article
-
Endocrine therapy for breast cancer. Academic Article
-
Endocrine therapy of advanced disease: analysis and implications of the existing data. Academic Article
-
Endocrine therapy: is the first generation of targeted drugs the last? Academic Article
-
Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies Academic Article
-
Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women Academic Article
-
Endometrial Evaluation with Transvaginal US and Hysterosonography in Asymptomatic Postmenopausal Women with Breast Cancer Receiving Tamoxifen Academic Article
-
Endometrial cancer. Prevention, detection, management, and follow up. Academic Article
-
Estrogen receptor: is it predictive for response to cytotoxic as well as hormonal therapy? Academic Article
-
Evaluating the Feasibility of Performing Window of Opportunity Trials in Breast Cancer Academic Article
-
Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC) Academic Article
-
Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions Academic Article
-
Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion Academic Article
-
GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model1Contributed equally and share first authorship. Academic Article
-
Growth in Children With Acute Lymphoblastic Leukemia During Treatment Academic Article
-
Health-Related Quality of Life in Men With Metastatic Prostate Cancer Treated With Prednisone Alone or Mitoxantrone and Prednisone Academic Article
-
High non-compliance in the use of letrozole after 2.5years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial Academic Article
-
Hormone Replacement Therapy after Treatment for Breast Cancer: Physicians' Attitudes towards Randomized Trials Academic Article
-
Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer Academic Article
-
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials Academic Article
-
Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer Academic Article
-
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17 Academic Article
-
Locally advanced breast cancer in octogenarian women Academic Article
-
Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues Academic Article
-
Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer Academic Article
-
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 Academic Article
-
New-onset psychosis following androgen deprivation therapy for prostate cancer. Academic Article
-
Novel strategies for systemic treatment of endometrial cancer Academic Article
-
Obesity and Hormone Therapy in Breast Cancer: An Unfinished Puzzle Academic Article
-
Oligodendroglioma Academic Article
-
Ovarian ablation as adjuvant therapy for early-stage breast cancer Academic Article
-
Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer Academic Article
-
Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations. Academic Article
-
PREDICTORS OF PATHOLOGICAL STAGE BEFORE NEOADJUVANT ANDROGEN WITHDRAWAL THERAPY AND RADICAL PROSTATECTOMY Academic Article
-
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide Academic Article
-
Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx Academic Article
-
Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer Academic Article
-
Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer Academic Article
-
Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01 Academic Article
-
Postmenopausal breast cancer: is the short-term pain worth the long-term gain? Academic Article
-
Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer Academic Article
-
Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model Academic Article
-
Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: Conference Summary Statement Conference Paper
-
Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario Academic Article
-
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer Academic Article
-
Prospects of the Clinical Utilization of Melatonin Academic Article
-
Prostate cancer: risk categories and role of hormones and radiotherapy. Academic Article
-
Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE−/−:Ins2+/Akita mouse model Academic Article
-
Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question Academic Article
-
Randomised clinical trial: the safety and efficacy of long-acting octreotide in patients with portal hypertension Academic Article
-
Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14 Academic Article
-
Rehabilitation in primary and metastatic brain tumours Academic Article
-
Remission of Macroglobulinemia during Anastrozole Treatment for Breast Cancer Academic Article
-
Resolution of Catamenial Epilepsy after Goserelin Therapy and Oophorectomy: Case Report of Presumed Cerebral Endometriosis Academic Article
-
Role of Gonadotropin-Releasing Hormone Analog in the Management of Male Metastatic Breast Cancer Is Uncertain Academic Article
-
Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds Academic Article
-
Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement. Academic Article
-
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study Academic Article
-
Sensitization of human melanoma cells by tamoxifen to apoptosis induction by pancratistatin, a nongenotoxic natural compound Academic Article
-
Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer Academic Article
-
Symptoms and Cancer Outcome in Adjuvant Endocrine Therapy for Breast Cancer: Why Are They Associated? Academic Article
-
Synergy of pancratistatin and tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria Academic Article
-
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Academic Article
-
Tamoxifen Derivatives for Delivery of the Antitumoral (DACH)Pt Group: Selective Synthesis by McMurry Coupling, and Biochemical Behaviour Academic Article
-
Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status Academic Article
-
Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study? Academic Article
-
Tamoxifen for Breast Cancer Risk Reduction Academic Article
-
The First Organometallic Selective Estrogen Receptor Modulators (SERMs) and Their Relevance to Breast Cancer Academic Article
-
The association between tamoxifen and the development of hepatocellular carcinoma: case report and literature review. Academic Article
-
The best use of adjuvant endocrine treatments Conference Paper
-
The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures Academic Article
-
The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma Academic Article
-
The experiences of men receiving androgen deprivation treatment for prostate cancer: a qualitative study. Academic Article
-
The role of tamoxifen and aromatase inhibitors/inactivators in postmenopausal patients. Academic Article
-
The use and toxicity of steroids in the management of patients with brain metastases Academic Article
-
Therapeutic options in advanced prostate cancer: Present and future Academic Article
-
Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study Academic Article
-
Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial Academic Article
-
Trends in Hormonal Management of Prostate Cancer: Academic Article
-
Trends in endocrine therapy and chemotherapy for early breast cancer: a focus on the premenopausal patient Academic Article
-
Words or Wisdom: Re: The Incidence and Relative Risk of Cardiovascular Toxicity in Patients Treated with New Hormonal Agents for Castration-resistant Prostate Cancer. Academic Article
-
[Medroxyprogesterone Acetate as Part of Palliative Care for Terminal-Stage Breast Cancer Patients--A Report of Two Cases]. Academic Article